Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.04% to 10748.16, DAX (0.42%) to 25983.04, CAC40 (0.57%) to 8453.09, STOXX 600 (0.12%) to 650.35

Aug 20 ,2026

  • Synopsis:

    • European equity markets closed mixed with France the leading underperformer (0.5%) and Finland topping outperformers +0.7%. Energy, utilities and food and beverage led outperforming sectors whilst retail, telecom and personal and household goods lagged. Stoxx 600 headed to the seventh daily decline in a row, down ~1% on the week. Follows mixed performance on Wednesday.

    • US-Iran development an ongoing influence due to energy dynamics. Trump announced "unprecedented" economic pressure campaign against Iran but did not go in specifics.

    • On the macro calendar, Riksbank left policy unchanged at 1.75% as expected but left door open to a hike later this year. Swiss trade surplus hit record high. German PPI for July 1.1% m/m versus 0.7% expected but ex-energy, monthly read was flat. CBI Industrial Trends survey saw improvement in UK manufacturing sector. French bond auctions saw good demand.

    • In corporate news, Aegon (AGN.NA) reported better-than-expected H1 earnings and reaffirmed its 2026 targets; Novonesis (NSIS.B.DC) reported Q2 earnings with strong organic growth, raised guidance for 2026, and approved share buyback program of up to €1B. In the UK, Standard Life (SDLF.LN) announced a major strategic partnership with CVC, Prudential Financial and Goldman Sachs to expand its Pension Risk Transfer business with up to £2B in capital commitments. JD Sports Fashion (JD.LN) trimmed its FY27 profit guidance to £700-800M, citing weak like-for-like sales. Ashtead Technology (AT.LN) issued a profit warning, guiding revenues and EBITA ~ 5-15% below consensus, respectively, due to Middle East conflict and broader project delays. Elsewhere, Mayr-Melnhof Karton (MMK.AV) and Orkla (ORK.NO) both reported broadly in line results.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Oil & Gas +0.91%, Utilities +0.47%, Food & Beverage +0.27%, Real Estate +0.26%, Health Care +0.16%, Chemicals +0.08%, Basic Resources (0.07%), Banks (0.11%)

      • Underperformers:

        • Retail (1.02%), Telecom (0.97%), Persnl & HHold Goods (0.68%), Travel & Leisure (0.57%), Insurance (0.48%), Ind Goods & Svcs (0.40%), Financial Svcs (0.25%), Media (0.23%), Technology (0.20%), Construct & Mtls (0.17%), Autos & Parts (0.14%)

    • Macro:

      • Geopolitics

        • Trump threatens Iran's trade partners, as military strikes make way for economic pressure - The Guardian

        • Israeli warns Turkey against 'dangerous adventures' in Syria; Syria says no Turkish build-up planned - Reuters

      • Central Banks

        • Sweden's Riksbank Holds Rate and Restates Chance of Hike This Year - Bloomberg

      • EU

        • China hits out at EU probe into JD.com bid for German retailer - FT

      • UK

        • Healey 'risks £11bn Budget black hole' from Iran war - The Telegraph

        • Nearly nine in 10 leasehold flats still on the market after six months - FT

      • France

        • Bond Investors Choose Italy Over France as Elections Loom -Bloomberg

        • Rising unemployment rate scuppers Macron's pledge to achieve full employment - Le Monde

      • Germany

        • Which parties in eastern Germany are ahead according to polls - Handelsblatt

        • Ifo boss Fuest calls on government to act - Handelsblatt

      • Norway

        • Norway Readies for More US Tariffs After Trade Talks in DC - Bloomberg

    • Company news:

      • Notable Gainers

        • +31.0% ALCLA.FP (Claranova €0.80, +0.19) -- strategic distribution agreement with Vertosoft

        • +22.8% CBRAIN.DC (cBrain DKK67.40, +12.50) -- earnings

        • +11.6% CAPD.LN (Capital £1.20, +0.13) -- earnings

        • +11.4% TRMED.NO (Thor Medical NOK6.37, +0.65) -- initiated buy at ABG Sundal Collier

        • +10.7% KAR.SS (Karnov Group SEK80.00, +7.70) -- earnings

        • +10.2% STX.LN (Shield Therapeutics £0.05, -0.00) -- earnings

        • +10.1% MVIR.SS (Medivir SEK1.86, +0.17) -- earnings

        • +9.6% NSIS.B.DC (Novonesis DKK452.30, +39.80) -- earnings; €1B share buyback

        • +9.0% F85.GR (Contango Silver & Gold, Inc. €17.14, +1.42)

        • +7.3% ACE.SS (Ascelia Pharma SEK0.59, +0.04) -- earnings

        • +6.9% BURE.SS (Bure Equity SEK289.60, +18.60) -- earnings

        • +6.8% TYRES.FH (Nokian Renkaat €15.83, +1.01) -- JPMorgan upgrade

        • +6.6% DIM.FP (Sartorius Stedim Biotech €195.00, +12.10) -- UBS upgrade

        • +6.1% SRT3.GR (Sartorius €248.90, +14.20) -- UBS upgrade

        • +5.1% DECB.BB (Deceuninck €2.35, +0.12) -- earnings

        • +4.8% OLE.SM (Deoleo €0.48, +0.02) -- earnings

        • +4.4% SGG.SS (Sensys Gatso Group SEK44.30, +1.85) -- earnings

        • +3.7% KIN.BB (Kinepolis Group €44.35, +1.60) -- earnings

        • +3.3% BIOPOR.DC (BioPorto DKK1.25, +0.04) -- earnings

        • +3.2% DOCM.SW (DocMorris CHF10.32, +0.32)

        • +3.2% B2I.NO (B2 Impact NOK25.80, +0.80) -- earnings

        • +2.7% ACTI.SS (Active Biotech SEK5.30, +0.14) -- earnings

        • +2.7% AXFO.SS (Axfood SEK243.40, +6.30) -- Danske Bank upgrade

        • +2.4% BTLS.BB (Biotalys €2.75, +0.06) -- earnings

        • +2.2% SKA.B.SS (Skanska SEK268.20, +5.90) -- contract

        • +2.1% JYSK.DC (Jyske Bank DKK1,062.00, +22.00) -- SEB upgrade

        • +1.5% MINEST.SS (Minesto SEK1.78, +0.03) -- earnings

      • Notable Decliners

        • -18.3% NORSE.NO (Norse Atlantic NOK0.31, -0.07) -- earnings

        • -16.5% AT.LN (Ashtead Technology Holdings £3.58, -0.71) -- trading update; lowers FY guidance

        • -14.3% JD.LN (JD Sports Fashion £0.80, -0.13) -- trading update

        • -11.9% HAUTO.NO (Höegh Autoliners NOK169.50, -22.80) -- earnings

        • -10.5% GN.DC (GN Store Nord DKK90.20, -10.55) -- earnings

        • -10.5% WSTEP.NO (Webstep $14.10, -1.65) -- earnings

        • -9.9% SYNACT.SS (SynAct Pharma SEK19.32, -2.13) -- earnings

        • -9.0% TRN.LN (Trainline £1.90, -0.19)

        • -7.4% IDEX.NO (IDEX Biometrics NOK7.50, -0.60) -- earnings

        • -6.7% ORK.NO (Orkla NOK96.30, -6.90) -- earnings

        • -5.4% TNIE.GR (tonies €11.64, -0.66) -- earnings

        • -5.3% MMK.AV (Mayr-Melnhof Karton €76.50, -4.30) -- earnings

        • -5.3% NANOFH.FH (Nanoform Finland €0.91, -0.05) -- earnings

        • -5.0% ARYN.SW (Aryzta CHF42.45, -2.25) -- UBS downgrade

        • -4.8% HAS.LN (Hays Plc £0.68, -0.03) -- earnings

        • -4.7% UQA.AV (UNIQA Insurance Group €17.16, -0.84) -- earnings

        • -4.5% VISTN.NO (Vistin Pharma NOK19.30, -0.90) -- earnings

        • -4.4% GREAT.SS (Greater Than SEK9.66, -0.44) -- earnings

        • -4.2% CAT.B.SS (Catella SEK18.50, -0.82) -- earnings

        • -3.5% GUBRA.DC (Gubra A/S DKK381.00, -14.00) -- earnings

        • -3.4% FG.SS (Fasadgruppen Group SEK19.90, -0.70) -- earnings

        • -3.3% IR5B.ID (Irish Continental Group €7.02, -0.24) -- earnings; update on proxy votes

        • -3.1% SAX.GR (Stroeer SE & Co. KGaA €39.00, -1.26) -- Kepler Cheuvreux downgrade

        • -3.0% NKR.NO (Nekkar NOK14.35, -0.45) -- earnings

        • -2.9% TCM.DC (TCM Group DKK67.80, -2.00) -- earnings

        • -2.9% AGN.NA (Aegon €7.80, -0.23) -- earnings; CFO to step down

        • -2.3% SOLB.BB (Solvay €25.26, -0.60) -- Kepler Cheuvreux downgrade

        • -2.3% NORCO.NO (Norconsult NOK37.60, -0.90) -- earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: What's Cooking Group (WHATS.BB), Roularta Media Group (ROU.BB)

        • Denmark: Copenhagen Airports (KBHL.DC), Bavarian Nordic (BAVA.DC)

        • Finland: Apetit (APETIT.FH), Modulight (MODU.FH)

        • Germany: Lang & Schwarz (LUS1.GR)

        • Norway: Scatec (SCATC.NO), Arendals Fossekompani (AFK.NO), Akastor (AKAST.NO), Zalaris (ZAL.NO), Otello Corp. (OTEC.NO), ALNG (ALNG.NO), Hofseth BioCare (HBC.NO)

        • Sweden: NIBE Industrier (NIBE.B.SS), Synsam (SYNSAM.SS), Egetis Therapeutics (EGTX.SS), Vicore Pharma Holding (VICO.SS), Implantica (IMP.A.SS), SaltX Technology Holding (SALT.B.SS), Paxman (PAX.SS), I-Tech (ITECH.SS), Pierce Group (PIERCE.SS), Duroc (DURC.B.SS)

        • Switzerland: Siegfried Holding (SFZN.SW), Vetropack Holding (VETN.SW)

        • UK: Kazatomprom (KAP.LN), Hunting (HTG.LN)

      • CMD/Events: Rockwool (ROCK.B.DC) - CEO, CFO and IR meeting at DNB Carnegie, Marshalls (MSLH.LN) - leadership team live interactive presentation on the Engage Investor platform at 9:00BST (registration link), Netel (NETEL.SS) and Infrea (INFREA.SS) EGMs to vote on proposed merger

  • Data:

    • Economics:

      • Netherlands Jul Unemployment Rate 4.0% vs consensus 3.9% and prior 3.8%

      • Germany Jul PPI +3.0% y/y vs consensus +2.7% and prior +1.8%

      • Denmark Q2 Preliminary GDP +4.6% y/y vs consensus +4.6% and prior +6.2%

      • Switzerland Jul Trade Balance CHF8.73B vs prior CHF5.05B revised from CHF5.22B

      • July Swiss Watch Exports +9.6% to CHF 2.63B

      • Eurozone Jun Construction Output (0.7%) y/y consensus +0.6% and prior revised +0.7% from +1.2%

    • Markets:

      • WTI Crude (Sep 26): +$2.20 or +2.56% to $88.03

      • €-$ +0.0000 or +0.00% to 1.1680

      • £-$ +0.0031 or +0.23% to 1.3638

      • €-£ (0.0019) to 0.8566

      • S&P 500 (0.39%)

      • Performance year-to-date

        • FTSE 100: +8.22%

        • DAX: +6.09%

        • CAC: +3.73%

        • MIB: +17.18%

        • Stoxx 600: +9.82%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.